Total Payments
$32,141
2024 Payments
$3,683
Companies
73
Transactions
1,447
Medicare Patients
21,793
Medicare Billing
$4.2M
Payment Breakdown by Category
Food & Beverage$30,324 (94.3%)
Travel$1,668 (5.2%)
Consulting$100.00 (0.3%)
Education$49.82 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $30,324 | 1,432 | 94.3% |
| Travel and Lodging | $1,668 | 9 | 5.2% |
| Consulting Fee | $100.00 | 1 | 0.3% |
| Education | $49.82 | 5 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $16,260 | 605 | $0 (2024) |
| Boston Scientific Corporation | $3,782 | 181 | $0 (2024) |
| Vertos Medical, Inc. | $2,694 | 140 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $1,973 | 119 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $744.20 | 55 | $0 (2024) |
| ABBVIE INC. | $681.08 | 30 | $0 (2024) |
| SCILEX PHARMACEUTICALS INC. | $635.31 | 28 | $0 (2024) |
| IBSA Pharma Inc. | $337.01 | 16 | $0 (2024) |
| Medtronic USA, Inc. | $297.70 | 22 | $0 (2020) |
| Egalet US Inc | $256.19 | 27 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,683 | 154 | Abbott Laboratories ($722.71) |
| 2023 | $4,542 | 227 | Abbott Laboratories ($1,946) |
| 2022 | $6,690 | 288 | Abbott Laboratories ($3,831) |
| 2021 | $4,677 | 258 | Abbott Laboratories ($3,018) |
| 2020 | $4,473 | 160 | Abbott Laboratories ($2,133) |
| 2019 | $4,096 | 143 | Abbott Laboratories ($2,455) |
| 2018 | $2,378 | 125 | Abbott Laboratories ($1,524) |
| 2017 | $1,602 | 92 | Abbott Laboratories ($630.81) |
All Payment Transactions
1,447 individual payment records from CMS Open Payments — Page 1 of 58
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 12/13/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/12/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/11/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/03/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: Analgesic | ||||||
| 11/27/2024 | Stryker Corporation | MILD DEVICE KIT (Device) | Food and Beverage | In-kind items and services | $36.89 | General |
| Category: INSTRUMENTS | ||||||
| 11/25/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $3.70 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 11/15/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: Neuromodulation | ||||||
| 11/15/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/14/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $17.78 | General |
| Category: Opioid Analgesic | ||||||
| 11/13/2024 | Stryker Corporation | MILD DEVICE KIT (Device) | Food and Beverage | In-kind items and services | $25.29 | General |
| Category: INSTRUMENTS | ||||||
| 11/08/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/07/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Central Nervous System | ||||||
| 10/30/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 10/28/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Neuroscience | ||||||
| 10/25/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/23/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $30.28 | General |
| 10/23/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $17.16 | General |
| Category: Opioid Analgesic | ||||||
| 10/15/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $25.72 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/09/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $23.71 | General |
| Category: Opioid Analgesic | ||||||
| 10/08/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/26/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $23.54 | General |
| Category: Opioid Analgesic | ||||||
| 09/25/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: Neuromodulation | ||||||
| 09/25/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Neuromodulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 43 | 7,093 | 27,584 | $9.8M | $1.4M |
| 2022 | 43 | 6,134 | 19,551 | $8.6M | $1.2M |
| 2021 | 40 | 4,859 | 14,801 | $7.3M | $981,838 |
| 2020 | 39 | 3,707 | 11,398 | $3.7M | $615,937 |
Total Patients
21,793
Total Services
73,334
Medicare Billing
$4.2M
Procedure Codes
213
All Medicare Procedures & Services
213 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 1,102 | 4,088 | $2.7M | $427,695 | 16.0% |
| 0275T | Removal of bone from lower spine for decompression of nerve tissue using imaging guidance, accessed through the skin | Facility | 2023 | 139 | 155 | $891,250 | $123,473 | 13.9% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 401 | 1,368 | $410,800 | $83,311 | 20.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 272 | 1,597 | $327,864 | $82,091 | 25.0% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 169 | 331 | $331,000 | $80,095 | 24.2% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 232 | 699 | $404,775 | $78,386 | 19.4% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 234 | 293 | $412,280 | $64,886 | 15.7% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 179 | 351 | $273,780 | $53,864 | 19.7% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 153 | 186 | $290,316 | $42,988 | 14.8% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 125 | 164 | $247,846 | $32,374 | 13.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 181 | 181 | $201,607 | $32,363 | 16.1% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 102 | 138 | $196,664 | $30,569 | 15.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 165 | 165 | $139,260 | $23,218 | 16.7% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 120 | 202 | $123,140 | $20,430 | 16.6% |
| 63650 | Insertion of spinal neurostimulator electrode array through skin | Facility | 2023 | 24 | 75 | $907,976 | $19,782 | 2.2% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 37 | 47 | $121,787 | $19,224 | 15.8% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 1,089 | 3,985 | $106,182 | $16,033 | 15.1% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 116 | 154 | $119,087 | $15,734 | 13.2% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 44 | 64 | $92,588 | $12,269 | 13.3% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 56 | 72 | $90,851 | $12,105 | 13.3% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 96 | 114 | $66,508 | $10,954 | 16.5% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 35 | 48 | $50,099 | $10,683 | 21.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 101 | 173 | $65,230 | $10,344 | 15.9% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 67 | 77 | $142,550 | $8,669 | 6.1% |
| 27095 | Injection of contrast for imaging of hip under anesthesia | Office | 2023 | 26 | 29 | $49,214 | $7,848 | 15.9% |
About Dr. Philip Sasso, M.D
Dr. Philip Sasso, M.D is a Specialist healthcare provider based in Abington, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1831191089.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Philip Sasso, M.D has received a total of $32,141 in payments from pharmaceutical and medical device companies, with $3,683 received in 2024. These payments were reported across 1,447 transactions from 73 companies. The most common payment nature is "Food and Beverage" ($30,324).
As a Medicare-enrolled provider, Sasso has provided services to 21,793 Medicare beneficiaries, totaling 73,334 services with total Medicare billing of $4.2M. Data is available for 4 years (2020–2023), covering 213 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Abington, PA
- Active Since 06/01/2005
- Last Updated 07/08/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1831191089
Products in Payments
- PROCLAIM (Device) $4,826
- Proclaim Family of SCS IPGs (Device) $4,387
- mild Device Kit (Device) $2,694
- Proclaim IPG (Device) $2,257
- XTAMPZA (Drug) $1,789
- SUPERION (Device) $1,491
- WaveWriter Alpha Prime 16 (Device) $1,275
- Octrode SCS Leads (Device) $765.71
- ETERNA (Device) $734.81
- SCS IPGs (Device) $703.47
- RELISTOR (Drug) $699.48
- OCTRODE (Device) $675.08
- ZTLido (Drug) $524.03
- UBRELVY (Drug) $435.06
- SCS leads (Device) $357.64
- Proclaim XR IPG (Device) $343.51
- NURTEC ODT (Drug) $310.91
- MOVANTIK (Drug) $243.75
- QULIPTA (Drug) $227.82
- INTELLIS (Device) $219.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Abington
Steven Cohen, M.d, M.D
Specialist — Payments: $43,866
Specialist $43,866
Jeremy Jaffe, M.d, M.D
Specialist — Payments: $24,784
Specialist $24,784
Lisette Volckmar, M.d, M.D
Specialist — Payments: $274.46
Specialist $274.46
Luis Mercader, M.d, M.D
Specialist — Payments: $273.90
Specialist $273.90
Robert Atkins, M.d, M.D
Specialist — Payments: $174.94
Specialist $174.94
Peter Vacca, M.d, M.D
Specialist — Payments: $115.46
Specialist $115.46